Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis
Status:
Enrolling by invitation
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
With the knowledge that VVC is an infectious disease of the genitourinary tract that is
common in women of reproductive age, and because of the shortage of non-drug therapies for
this condition, this study will aim to evaluate the effect of ultraviolet A/blue LED with a
wavelength of 401 ± 5 nm in patients with a clinical manifestation of candidiasis and its
ability to prevent recurrence.